| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $305.2M | +24.4% |
| Cost of Revenue | $65.6M | +19.0% |
| R&D Expense | $571.0M | +43.6% |
| SG&A Expense | $344.5M | +29.6% |
| Operating Income | -$709.6M | -55.2% |
| Interest Expense | $81.7M | +208.9% |
| Pre-tax Income | -$747.0M | -55.6% |
| Income Tax | $2.6M | +84.7% |
| Net Income | -$749.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $482.4M | -55.1% |
| Short-term Investments | $298.1M | +301.5% |
| Accounts Receivable | $41.2M | +38.6% |
| Inventory | $83.2M | +19.1% |
| Current Assets | $929.1M | -27.0% |
| Total Assets | $1.33B | -19.7% |
| Current Liabilities | $225.6M | +18.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$536.2M | -33.9% |
| Capital Expenditures | $13.3M | +34.5% |
| Investing Cash Flow | -$223.6M | -546.6% |
| Financing Cash Flow | $168.4M | -78.8% |
| Free Cash Flow | -$549.5M | -33.9% |
| -55.7% |
| EPS (Basic) | -$5.34 | -36.6% |
| EPS (Diluted) | -$5.34 | -36.6% |
| Long-term Debt |
| $1.18B |
| +2.0% |
| Total Liabilities | $1.66B | +5.9% |
| Stockholders' Equity | -$331.9M | -477.4% |